Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Siga Technologies ROE 2010-2025 | SIGA

Current and historical return on equity (ROE) values for Siga Technologies (SIGA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Siga Technologies ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $0.05B $0.22B 25.49%
2024-12-31 $0.06B $0.22B 32.87%
2024-09-30 $0.09B $0.17B 48.64%
2024-06-30 $0.08B $0.17B 51.38%
2024-03-31 $0.08B $0.17B 51.80%
2023-12-31 $0.07B $0.20B 44.81%
2023-09-30 $-0.01B $0.12B -3.45%
2023-06-30 $0.03B $0.12B 17.81%
2023-03-31 $0.03B $0.16B 20.47%
2022-12-31 $0.03B $0.17B 20.89%
2022-09-30 $0.11B $0.17B 65.95%
2022-06-30 $0.07B $0.14B 48.90%
2022-03-31 $0.07B $0.17B 49.47%
2021-12-31 $0.07B $0.17B 52.98%
2021-09-30 $0.02B $0.11B 13.42%
2021-06-30 $0.04B $0.12B 35.61%
2021-03-31 $0.06B $0.12B 55.65%
2020-12-31 $0.06B $0.13B 52.71%
2020-09-30 $0.03B $0.11B 31.55%
2020-06-30 $0.01B $0.09B 6.27%
2020-03-31 $-0.02B $0.09B -18.37%
2019-12-31 $-0.01B $0.10B -6.83%
2019-09-30 $0.05B $0.10B 48.19%
2019-06-30 $0.44B $0.10B 482.42%
2019-03-31 $0.44B $0.11B -2175.00%
2018-12-31 $0.42B $0.10B -323.22%
2018-09-30 $0.36B $0.05B -151.64%
2018-06-30 $-0.04B $-0.34B 11.89%
2018-03-31 $-0.04B $-0.34B 12.56%
2017-12-31 $-0.04B $-0.32B 11.98%
2017-09-30 $-0.04B $-0.31B 12.34%
2017-06-30 $-0.04B $-0.30B 12.01%
2017-03-31 $-0.04B $-0.30B 12.67%
2016-12-31 $-0.04B $-0.29B 13.01%
2016-09-30 $-0.05B $-0.31B 16.39%
2016-06-30 $-0.05B $-0.30B 16.03%
2016-03-31 $-0.04B $-0.30B 15.59%
2015-12-31 $-0.04B $-0.28B 15.08%
2015-09-30 $-0.04B $-0.27B 15.23%
2015-06-30 $-0.27B $-0.26B 110.64%
2015-03-31 $-0.27B $-0.25B 150.28%
2014-12-31 $-0.27B $-0.25B 236.08%
2014-09-30 $-0.25B $-0.23B 540.54%
2014-06-30 $-0.02B $0.01B -96.77%
2014-03-31 $-0.02B $0.01B -82.19%
2013-12-31 $-0.02B $0.02B -80.95%
2013-09-30 $-0.02B $0.02B -67.37%
2013-06-30 $-0.01B $0.02B -51.85%
2013-03-31 $-0.02B $0.03B -50.42%
2012-12-31 $-0.02B $0.03B -45.45%
2012-09-30 $0.00B $0.03B -5.52%
2012-06-30 $0.00B $0.03B 2.52%
2012-03-31 $0.03B $0.04B 69.05%
2011-12-31 $0.03B $0.04B 82.27%
2011-09-30 $-0.02B $0.05B -60.71%
2011-06-30 $-0.02B $0.04B -113.51%
2011-03-31 $-0.05B $0.01B -571.43%
2010-12-31 $-0.05B $0.01B -645.16%
2010-09-30 $-0.02B $0.01B -230.77%
2010-06-30 $-0.01B $0.00B -685.71%
2010-03-31 $-0.02B $0.01B 680.00%
2009-12-31 $-0.02B $0.01B 330.43%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.440B $0.139B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.912B 32.23
Zoetis (ZTS) United States $74.412B 27.76
Daiichi Sankyo, - (DSNKY) Japan $51.611B 26.26
Takeda Pharmaceutical (TAK) Japan $47.092B 9.37
Sandoz Group AG (SDZNY) Switzerland $21.516B 0.00
Summit Therapeutics (SMMT) United States $19.465B 0.00
Merck (MKKGY) Germany $16.963B 12.43
United Therapeutics (UTHR) United States $14.451B 12.78
Shionogi (SGIOY) Japan $13.900B 13.93
Neurocrine Biosciences (NBIX) United States $12.238B 41.92
IPSEN (IPSEY) France $9.702B 0.00
Orion OYJ (ORINY) Finland $9.462B 25.59
Corcept Therapeutics (CORT) United States $8.233B 66.93
Stevanato Group S.p.A (STVN) Italy $6.929B 42.37
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.993B 0.00
Grifols, S.A (GRFS) Spain $5.748B 0.00
Ionis Pharmaceuticals (IONS) United States $5.325B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.811B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.998B 10.50
Crinetics Pharmaceuticals (CRNX) United States $2.858B 0.00
Hypermarcas (HYPMY) Brazil $2.716B 17.87
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.288B 12.37
BioCryst Pharmaceuticals (BCRX) United States $2.277B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.979B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.809B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.746B 0.00
Indivior (INDV) United States $1.711B 7.26
ARS Pharmaceuticals (SPRY) United States $1.521B 0.00
Dyne Therapeutics (DYN) United States $1.391B 0.00
Guardian Pharmacy Services (GRDN) United States $1.354B 0.00
Evotec AG (EVO) Germany $1.342B 0.00
Ocular Therapeutix (OCUL) United States $1.297B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.079B 21.59
Harrow (HROW) United States $0.998B 0.00
Ardelyx (ARDX) United States $0.964B 0.00
Collegium Pharmaceutical (COLL) United States $0.938B 5.06
Avadel Pharmaceuticals (AVDL) Ireland $0.892B 0.00
Enliven Therapeutics (ELVN) United States $0.870B 0.00
Akebia Therapeutics (AKBA) United States $0.791B 0.00
Cronos Group (CRON) Canada $0.790B 0.00
Xeris Biopharma Holdings (XERS) United States $0.788B 0.00
AleAnna (ANNA) United States $0.603B 0.00
KalVista Pharmaceuticals (KALV) United States $0.591B 0.00
Elite Pharmaceuticals (ELTP) United States $0.576B 0.00
USANA Health Sciences (USNA) United States $0.562B 12.22
Xencor (XNCR) United States $0.551B 0.00
Regulus Therapeutics (RGLS) United States $0.550B 0.00
Bioventus (BVS) United States $0.539B 13.67
Relay Therapeutics (RLAY) United States $0.528B 0.00
Zevra Therapeutics (ZVRA) United States $0.471B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.465B 0.00
Altimmune (ALT) United States $0.455B 0.00
Oruka Therapeutics (ORKA) United States $0.444B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.437B 0.00
CytoDyn (CYDY) United States $0.435B 0.00
Tourmaline Bio (TRML) United States $0.424B 0.00
Verve Therapeutics (VERV) United States $0.410B 0.00
Savara (SVRA) United States $0.387B 0.00
Organogenesis (ORGO) United States $0.362B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.349B 9.43
Tonix Pharmaceuticals Holding (TNXP) United States $0.308B 0.00
Heron Therapeutics (HRTX) United States $0.291B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 25.92
Aquestive Therapeutics (AQST) United States $0.277B 0.00
MediWound (MDWD) Israel $0.231B 0.00
ProKidney (PROK) United States $0.211B 0.00
Nanobiotix S.A (NBTX) France $0.195B 0.00
Journey Medical (DERM) United States $0.188B 0.00
Esperion Therapeutics (ESPR) United States $0.173B 0.00
4D Molecular Therapeutics (FDMT) United States $0.172B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Profound Medical (PROF) Canada $0.160B 0.00
Aclaris Therapeutics (ACRS) United States $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.155B 0.00
OmniAb (OABI) United States $0.153B 0.00
Avita Medical (RCEL) United States $0.153B 0.00
Larimar Therapeutics (LRMR) United States $0.147B 0.00
Nektar Therapeutics (NKTR) United States $0.138B 0.00
Aldeyra Therapeutics (ALDX) United States $0.137B 0.00
Liminatus Pharma (LIMN) $0.136B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.132B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.119B 0.00
Achieve Life Sciences (ACHV) Canada $0.116B 0.00
Korro Bio (KRRO) United States $0.110B 0.00
VAXART, INC (VXRT) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Inotiv (NOTV) United States $0.096B 0.00
Lexeo Therapeutics (LXEO) United States $0.095B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Champions Oncology (CSBR) United States $0.085B 14.05
Galectin Therapeutics (GALT) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 55.89
ESSA Pharma (EPIX) Canada $0.074B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Unicycive Therapeutics (UNCY) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Metagenomi (MGX) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Avalo Therapeutics (AVTX) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
SHINECO (SISI) China $0.015B 0.00
Ainos (AIMD) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.83
Talphera (TLPH) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Aditxt (ADTX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00